Tenderwize
Retour à la recherche

Open House Rebate Agreements for Hydrocortisone 10mg Tablets/ Film Tablets

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Jan 03, 2028 · 492 days left·Open·Supplies·Framework
Inscrivez-vous pour sauvegarderOpen documents
Structured notice only
Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Hydrocortison in der Wirkstärke 10mg in den Darreichungsformen Tabletten und Filmtabletten, ATC H02AB09

40/100

Score d'opportunité

Needs reviewLow complexity
SuppliesFrameworkOpen
Pourquoi ce score ?

Opportunité

40 / 100

Complexité

20 / 100

Facteurs de risque

No estimated value or volume disclosed; the agreement is a discount contract with no guaranteed revenue. Revenue depend...

Contracts can be terminated with one month's notice. Buyers may also terminate if alternative contracts are concluded...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Feb 2028
  • Provision of Hydrocortisone 10mg (ATC H02AB09) in tablet and film tablet forms
  • Conclusion of non-exclusive rebate agreements under §130a SGB V with AOK Bayern
Afficher le résumé complet

This is an open-house model (not a public procurement procedure) for non-exclusive pharmaceutical discount agreements under §130a SGB V. The AOK Bayern invites all interested pharmaceutical companies to conclude identical, non-negotiable rebate contracts for Hydrocortisone 10mg tablets/film tablets (ATC H02AB09). No competitive selection; any eligible company can join. Contracts run from earliest March 1, 2026, to February 29, 2028. Submission is possible every month until Jan 3, 2028. No estimated value or volume is disclosed.

Risques

No estimated value or volume disclosed; the agreement is a discount contract with no guaranteed revenue. Revenue depend...

Contracts can be terminated with one month's notice. Buyers may also terminate if alternative contracts are concluded...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Eligibility

  • Only pharmaceutical companies (pharmazeutische Unternehmen) are eligible to participate

Administrative

  • Submission of a signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit)
  • Submission of signed contract and annex listing the specific pharmaceutical products

Les exigences peuvent être incomplètes.

Acheteur

Localisation

München, DEU

Site web

www.aok.de

Profil acheteur

Ouvrir le profil

Identifiant

DE811695320

Activité

Health

Lots (1)

LOT-0001

Open House Rebate Agreements for Hydrocortisone 10mg Tablets/ Film Tablets

Single lot covering all pharmaceutical products with active ingredient Hydrocortisone 10mg, in tablet and film tablet forms, ATC H02AB09. Non-exclusive rebate agreements offered to all qualified pharmaceutical companies on identical terms.

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE212, Germany

Durée

Feb 2026 - Feb 2028

Catégorie

Pharmaceutical products

Date limite

Deadline Jan 03, 2028

Détails de la procédure

Date de publication
13 Jan 2026
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
22791-2026

Documents (2)

Document de consultation 1Portail de soumission 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30